⌘K

Login Start Free

Home/Filings/4/0001363585-13-000007

4//SEC Filing

GENEREX BIOTECHNOLOGY CORP 4

Accession 0001363585-13-000007

CIK 0001059784operating

View on SEC.gov Company Profile

Filed

Mar 31, 8:00 PM ET

Accepted

Apr 1, 4:38 PM ET

Size

5.6 KB

Accession

0001363585-13-000007

Insider Transaction Report

Form 4

Period: 2013-04-01

GENEREX BIOTECHNOLOGY CORPGNBT

EVP & General Counsel

Transactions

Award
Common Stock Purchase Option (right to buy)
2013-04-01+5,143,787→ 5,143,787 total
Exercise: $0.00From: 2013-04-01Exp: 2018-04-01→ COMMON STOCK (5,143,787 underlying)

Footnotes (1)

[F1]On March 5, 2013, the Board of Directors of the issuer granted the reporting person options to purchase 5,143,787 shares of the issuer's common stock in lieu of cash payment of deferred compensation, which grant was effective upon the reporting person's execution of a Settlement and Release Agreement with the issuer effective April 1, 2013. The grant was made pursuant to the terms of the issuer's 2006 stock plan.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

GENEREX BIOTECHNOLOGY CORP

CIK 0001059784

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001059784

Filing Metadata

Form type: 4
Filed: Mar 31, 8:00 PM ET
Accepted: Apr 1, 4:38 PM ET
Size: 5.6 KB

View on SEC.gov